Article Sidebar

Submitted
June 25, 2021
Accepted
July 26, 2022
Published
May 31, 2022
Download
Pdf
Statistic
Read Counter : 504 Download : 790

Main Article Content

Abstract

Background: Primary hyperhidrosis is a condition of excessive sweating on certain parts of the body with unknown cause. The severity and location of primary hyperhidrosis vary and are thought to affect the quality of life.

Purpose: The study aims to determine the association between severity and locations of primary hyperhidrosis and quality of life in medical students.

Methods: This study was conducted on 77 medical students at Atma Jaya Catholic University of Indonesia. Hyperhidrosis Disease Severity Scale (HDSS) questionnaire and Hyperhidrosis Quality of Life Index (HidroQoL) questionnaire were used. Data analysis was performed using Chi-Square.

Results: The prevalence of primary hyperhidrosis was 15.33%. Mild-moderate hyperhidrosis was found in 77.9% respondents, while severe-very severe hyperhidrosis was found in 22.1% respondents. The location of hyperhidrosis was found in palmar (66.1%), axillary (28.6%), plantar (1.0%), and other locations such as the face, thigh, and back (9.1%). The score of the daily activity domain (29.65 ± 21.96) was higher than the psychosocial score (27.92 ± 20.46). Data showed that 33.3% of respondents with mild-moderate hyperhidrosis and 82.4% of respondents with severe-very severe hyperhidrosis’ quality of life were affected by their excessive sweating (p=0,000). As many as 34.0% of respondents with palmar hyperhidrosis and 54.5% with axillary hyperhidrosis’ quality of life were all affected by their conditions (p=0,106).

Conclusion: We found a significant association between the severity of primary hyperhidrosis and the quality of life, and no significant association between the location of primary hyperhidrosis and quality of life among medical students.

Keywords

HDSS HidroQoL hyperhidrosis university students

Article Details

Author Biographies

Catherine Patricia Soetedjo, Bachelor of Medicine Study Programme, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta

Bachelor of Medicine Study Programme, School of Medicine and Health Sciences

Lorettha Wijaya, Department of Dermatology and Venerology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta

Department of Dermatology and Venereology, School of Medicine and Health Sciences, instructor

Regina Regina, Department of Dermatology and Venerology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta

Department of Dermatology and Venereology, School of Medicine and Health Sciences, instructor

Yunisa Astiarani, Department of Public Health and Nutrition, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta

Department of Public Health and Nutrition, School of Medicine and Health Sciences, instructor

How to Cite
Soetedjo, C. P., Wijaya, L., Regina, R., & Astiarani, Y. (2022). Association between severity and locations of primary hyperhidrosis and quality of life among medical students. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 13(1). https://doi.org/10.20885/JKKI.Vol13.Iss1.art4
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Schick CH. Pathophysiology of hyperhidrosis. Thorac Surg Clin NA. 2016;26:389-93.
  2. Sobrinho S, Fiorelli RK, Morard MR. Evaluation of the quality of life of patients with primary hyperhidrosis submitted to video thoracoscopic sympathectomy. Rev Col Bras Cir. 2017 Aug;44(4):323-7.
  3. Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LP. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51:274-86.
  4. Lima SO, Aragao JF, Machado NJ, Almeida KB, Menezes LM, Santana VR. Research of primary hyperhidrosis in students of medicine of the state of Sergipe, Brazil. An Bras Dermatol. 2015;90:661–5.
  5. Hexsel D, Camozzato FO. Hyperhidrosis. In: Dermatology in Public Health Environments. Springer; 2018:1379-93.
  6. Moraites E, Vaughn OA, Hill S. Incidence and prevalence of hyperhidrosis. Dermatol Clin. 2014;32:457-65.
  7. Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology. 2013;227:10–3.
  8. Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol. 2013;40:886–90.
  9. Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75(6):1126–33.
  10. Morard MR, Martins RB, Ribeiro AC, Lima PG, dos Santos Carvalho B, Junior JC. Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro. PloS one. 2019;14(9).
  11. Hamm H, Naumann MK, Kowalski JW, Kütt S, Kozma C, Teale C. Primary focal hyperhidrosis:disease characteristics and functional impairment. Dermatology. 2006;212:343–53.
  12. Hamm, H. Impact of Hyperhidrosis on Quality of Life and its Assessment. Dermatol Clin. 2014; 32(4):467–6.
  13. Kouris A, Armyra K, Christodoulou C, Karimali P, Karypidis D, Kontochristopoulos G. Quality of life in patients with focal hyperhidrosis before and after treatment with botulinum toxin A. ISRN Dermatology. 2014 Feb 6;2014.
  14. Westphal FL, de Carvalho MA, Lima LC, de Carvalho BC, Padilla R, Araujo KK. Prevalence of hyperhidrosis among medical students. Rev Col Bras Cir. 2011; 38(6):392–7.
  15. Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016; 308(10):743–9.
  16. Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg. 2007;33:S69-75.
  17. Kamudoni P, Mueller B, Halford J, et al. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes. 2017;15:121.
  18. Shayesteh A, Janlert U, Nylander E. Hyperhidrosis-sweating sites matter: quality of life in primary hyperhidrosis according to the sweating sites measured by SF-36. Dermatology. 2018;233(6):441–5.
  19. Connor KM, Cook JL, Davidson JR. Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial. J Clin Psychiatry. 2006;67(1):30-6.
  20. Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLoS One. 2014;9(3):e92412.
  21. Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatol Clin. 2014;32(4):485-90.
  22. Harker, M. Psychological sweating: a systematic review focused on aetiology and cutaneous response. Skin Pharmacol Physiol. 2013;26.2:92-100.